SCHEMBL11714059

SCHEMBL11714059

CCCCN(CCCC)CCCCOc1ccc(C(=O)c2ccc(N)c(N)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 1/20 0.57
▸ THRB P10828 1/20 0.57
▸ BCHE P06276 8/20 0.53
▸ ACHE P22303 6/20 0.53
▸ LMNA P02545 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CHRM2 P08172 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ HTR1A P08908 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ DRD3 P35462 1/20 0.47
▸ SCN1A P35498 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ SCN2A Q99250 1/20 0.47
▸ SCN3A Q9NY46 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11712203 0.96 THRA (0.55) THRATHRBBCHEACHELMNA
SCHEMBL11719732 0.95 THRA (0.54) THRATHRBBCHEACHELMNA
SCHEMBL11715650 0.95 BCHE (0.53) THRATHRBBCHEACHE
SCHEMBL11719494 0.91 BCHE (0.58) BCHEACHECYP1A2CYP2D6SCN1A
SCHEMBL11718751 0.91 BCHE (0.52) THRATHRBBCHEACHELMNA
SCHEMBL11713999 0.90 THRA (0.51) THRATHRBBCHEACHELMNA
SCHEMBL11717604 0.88 BCHE (0.59) BCHEACHELMNACYP1A2CYP2D6
SCHEMBL11715756 0.88 BCHE (0.51) THRATHRBBCHEACHELMNA
SCHEMBL11719155 0.86 KDM4E (0.52) THRATHRBBCHEACHE
SCHEMBL11717138 0.86 THRA (0.49) THRATHRBBCHELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4010272-A ANTHELMINTICALLY ACTIVE BASICALLY SUBSTITUTED 2-CARBALKOXY-AMINO-BENZIMIDAZOLYL-5(6)-PHENYL ETHERS AND -KETONES HOECHST AKTIENGESELLSCHAFT (DT) 1977-03-01 — — US disclosed
Send feedback